Seaport Therapeutics Statistics
NASDAQ: SPTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.93+0.56 (+3.22%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Seaport Therapeutics by the numbers
Seaport Therapeutics has a market capitalization of $959.8 million based on 53.53M shares outstanding. With trailing EPS of $-5.81, Seaport Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.2% below its 50-day average and 11.8% below its 200-day average.
Average daily trading volume is 181.78K shares, or about $3.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SPTX valuation vs. peer median
| Metric | SPTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $959.80M | $936.09M | +3% |
| Avg. volume | 181.78K | 562.32K | -68% |
Peer median across 8 companies: KURA, ANRO, AKTS, SVRA, MLTX, PCRX, ANL, RIGL.
Valuation
- Market cap
- $959.80M
- EPS (TTM)
- $-5.81
- Shares outstanding
- 53.53M
Price and trading
- Previous close
- 17.37
- Open
- 17.28
- Day range
- 17.07 – 18.29
- 52-week range
- 14.85 – 28.38
- Beta
- —
- Volume
- 249.08K
- Average volume
- 181.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 959.80M
- Forward Pe
- -6.97
- Eps
- -5.81
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 28.38
- Week52 Low
- 14.85
- Avg Volume
- 181.78K
- Shares Outstanding
- 53.53M
- Ma50
- 22.48
- Ma200
- 20.33
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -36.82%
- Pct From52w Low
- 20.74%